相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death
Rong Na et al.
EUROPEAN UROLOGY (2017)
New surgical approaches for clinically high-risk or metastatic prostate cancer
Paolo Dell'Oglio et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2017)
Sirtuin 3 Deficiency Accelerates Hypertensive Cardiac Remodeling by Impairing Angiogenesis
Tong Wei et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Giving AXL the axe: targeting AXL in human malignancy
Carl M. Gay et al.
BRITISH JOURNAL OF CANCER (2017)
WGSA: an annotation pipeline for human genome sequencing studies
Xiaoming Liu et al.
JOURNAL OF MEDICAL GENETICS (2016)
Targeting tumour vasculature by inhibiting activin receptor-like kinase (ALK)1 function
Amaya Garcia de Vinuesa et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2016)
RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data
Xiaowei Zhan et al.
BIOINFORMATICS (2016)
Rare Variation in TET2 Is Associated with Clinically Relevant Prostate Carcinoma in African Americans
Daniel C. Koboldt et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Familial Risk and Heritability of Cancer Among Twins in Nordic Countries
Lorelei A. Mucci et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer
Steven N. Hart et al.
BMJ OPEN (2016)
Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
Kenji Yumoto et al.
SCIENTIFIC REPORTS (2016)
Extracellular Matrix, a Hard Player in Angiogenesis
Maurizio Mongiat et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes
Z. Kote-Jarai et al.
ANNALS OF ONCOLOGY (2015)
Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer
Elena Castro et al.
EUROPEAN UROLOGY (2015)
Oncotator: Cancer Variant Annotation Tool
Alex H. Ramos et al.
HUMAN MUTATION (2015)
Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review)
Jun Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy
Jennifer L. Beebe-Dimmer et al.
BJU INTERNATIONAL (2014)
Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease
D. Leongamornlert et al.
BRITISH JOURNAL OF CANCER (2014)
The Heritability of Prostate Cancer in the Nordic Twin Study of Cancer
Jacob B. Hjelmborg et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2014)
A general framework for estimating the relative pathogenicity of human genetic variants
Martin Kircher et al.
NATURE GENETICS (2014)
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
Ali Amin Al Olama et al.
NATURE GENETICS (2014)
Pan-cancer genetic analysis identifies PARK2 as a master regulator of G1/S cyclins
Yongxing Gong et al.
NATURE GENETICS (2014)
STUDY DESIGNS Statistical power and significance testing in large-scale genetic studies
Pak C. Sham et al.
NATURE REVIEWS GENETICS (2014)
An inherited NBN mutation is associated with poor prognosis prostate cancer
C. Cybulski et al.
BRITISH JOURNAL OF CANCER (2013)
Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
Elena Castro et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study
Andrew J. Vickers et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
; Lumican Exhibits Anti-Angiogenic Activity in a Context Specific Manner
Bikram Sharma et al.
CANCER MICROENVIRONMENT (2013)
Detecting and Estimating Contamination of Human DNA Samples in Sequencing and Array-Based Genotype Data
Goo Jun et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Optimal Unified Approach for Rare-Variant Association Testing with Application to Small-Sample Case-Control Whole-Exome Sequencing Studies
Seunggeun Lee et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
GWASTools: an R/Bioconductor package for quality control and analysis of genome-wide association studies
Stephanie M. Gogarten et al.
BIOINFORMATICS (2012)
A high-performance computing toolset for relatedness and principal component analysis of SNP data
Xiuwen Zheng et al.
BIOINFORMATICS (2012)
Incorporating Prior Biologic Information for High-Dimensional Rare Variant Association Studies
Melanie A. Quintana et al.
HUMAN HEREDITY (2012)
wANNOVAR: annotating genetic variants for personal genomes via the web
Xiao Chang et al.
JOURNAL OF MEDICAL GENETICS (2012)
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano et al.
LANCET (2012)
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Charles M. Ewing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
ALK1 as an emerging target for antiangiogenic therapy of cancer
Sara I. Cunha et al.
BLOOD (2011)
BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
Z. Kote-Jarai et al.
BRITISH JOURNAL OF CANCER (2011)
Incorporating Model Uncertainty in Detecting Rare Variants: The Bayesian Risk Index
Melanie A. Quintana et al.
GENETIC EPIDEMIOLOGY (2011)
Using extreme phenotype sampling to identify the rare causal variants of quantitative traits in association studies
Dalin Li et al.
GENETIC EPIDEMIOLOGY (2011)
Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Joon-Il Jun et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Lumican inhibits angiogenesis by interfering with α2β1 receptor activity and downregulating MMP-14 expression
Jolanta Niewiarowska et al.
THROMBOSIS RESEARCH (2011)
PI3K/AKT/mTOR pathway in angiogenesis
Jayashree Karar et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2011)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
Mitochondrial HEP27 Is a c-Myb Target Gene That Inhibits Mdm2 and Stabilizes p53
Chad Deisenroth et al.
MOLECULAR AND CELLULAR BIOLOGY (2010)
Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing
Tom Walsh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
AmiGO: online access to ontology and annotation data
Seth Carbon et al.
BIOINFORMATICS (2009)
COPPER AND ANGIOGENESIS: UNRAVELLING A RELATIONSHIP KEY TO CANCER PROGRESSION
Lydia Finney et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2009)
Molecular characterization of human breast tumor vascular cells
Rajendra Bhati et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Human DNA repair genes, 2005
RD Wood et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2005)
NBS1 is a prostate cancer susceptibility gene
C Cybulski et al.
CANCER RESEARCH (2004)
分享论文
